Microsoft Word[removed]Thrombogenicity Panel Questions (final[removed]doc

First Page		Document Content
Coagulation system Hematology Blood tests Medical technology In vitro Hemodialysis Thrombogenicity Partial thromboplastin time Thrombus Medicine Biology Blood		Microsoft Word[removed]Thrombogenicity Panel Questions (final[removed]doc Add to Reading List Source URL: www.fda.gov Download Document from Source Website File Size: 146,34 KB Share Document on Facebook

	MATEC Web of Conferences 4, DOI: matecconf C Owned by the authors, published by EDP Sciences, 2013 DocID: 1fDMd - View Document
	Microsoft PowerPoint - FDA Thrombogenicity Presentation 14April2014 PPT.pptx [Read-Only] DocID: BfA1 - View Document
	PTT and PT Assays for Thrombogenicity Evaluation: An FDA Perspective Qijin Lu, Ph.D. In Vitro Blood Damage Assessment Lab Division of Solid and Fluid Mechanics DocID: B6IV - View Document
	PUBLIC WORKSHOP: RISK MITIGATION STRATEGIES TO ADDRESS PROCOAGULANT ACTIVITY IN IMMUNE GLOBULIN PRODUCTS DocID: qPDt - View Document
	Welcome and Overview of the Current FDA Approach to Thrombogenicity Evaluation Jennifer Goode, BS, Biomedical Engineer FDA Office of Device Evaluation Division of Cardiovascular Devices DocID: iifd - View Document